Publications by authors named "Yefa Yang"

Claim this Profile
C
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Jianyong Yang, Xinrong Yang, Yefa Yang, Yunke Yang, Chun Yang

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coil-assisted N-butyl cyanoacrylate embolization covered stent implantation for delayed hemorrhage in hepatobiliary and pancreatic surgery.
Cheng-Jian He, Xiang-Dong Wang, Nai-Jian Ge, Xue Liu, Jian Huang, Ye-Fa Yang

World J Gastrointest Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turning Waste into Treasure: Radiation Byproduct-Induced Fe(III)/Fe(II) Conversion for Efficient Ferroptosis to Improve Iodine-131-Based Transarterial Radioembolization for Liver Tumors.
Jiangnan Xu, Xiu Luo, Weiwei Su, Guorong Jia, Huawei Cai, Yefa Yang

ACS Appl Mater Interfaces· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive gastrointestinal hemorrhage and iodine-125 seed migration due to hepatogastric fistula: a case report and literature review.
Chengjian He, Jing Zhou, Naijian Ge, Xiaofeng Zhang, Xiangdong Wang, Yefa Yang

Transl Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases.
Xinhao Wang, Yefa Yang

Medicine (Baltimore)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portal vein embolization for closure of marked arterioportal shunt of hepatocellular carcinoma to enable radioembolization: A case report.
Xiang-Dong Wang, Nai-Jian Ge, Ye-Fa Yang

World J Gastrointest Surg· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Chun Yang

Liver Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular treatment of delayed arterial hemorrhage after radical operation for hilar cholangiocarcinoma.
Xiang-Dong Wang, Nai-Jian Ge, Cheng-Jian He, Jun-Jun Zhu, Wei Xu, Ye-Fa Yang

Hepatobiliary Pancreat Dis Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
Naijian Ge, Hongbo Wang, Chengjian He, Xiangdong Wang, Jian Huang, Yefa Yang

J Interv Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular treatment for delayed post-pancreaticoduodenectomy hemorrhage of unusual origin (splenic artery branch).
Xiangdong Wang, Chengjian He, Hai Li, Jian Huang, Naijian Ge, Yefa Yang

J Vasc Surg Cases Innov Tech· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portal vein embolization in the treatment of portal vein bleeding after percutaneous transhepatic biliary drainage: A case report and literature review.
Hai Li, Naijian Ge, Chengjian He, Xiangdong Wang, Wei Xu, Yefa Yang

J Interv Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization.
Chengjian He, Naijian Ge, Xiangdong Wang, Hai Li, Shiguang Chen, Yefa Yang

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Safety of Delayed Catheter Removal Technique in Percutaneous Trans-Hepatic Portal Vein Embolization.
Chengjian He, Naijian Ge, Yefa Yang

Technol Cancer Res Treat· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative study.
Peng-Peng Li, Gang Huang, Ning-Yang Jia, Ze-Ya Pan, Hui Liu, Yun Yang, Ye-Fa Yang

Hepatobiliary Surg Nutr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular therapy choices for different sites of delayed postoperative arterial hemorrhage after hepatobiliary pancreatic surgery: a retrospective study.
Xiaohe Yu, Xue Liu, Jian Huang, Shuqun Shen, Naijian Ge, Yefa Yang

Gland Surg· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report.
Xiao-He Yu, Jian Huang, Nai-Jian Ge, Ye-Fa Yang, Jin-Yan Zhao

World J Clin Cases· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Jianhua Wang, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang

Liver Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial.
Jun Li, Jingliang Xing, Yefa Yang, Jingfeng Liu, Wentao Wang, Tian Yang, Hongyang Wang

Lancet Gastroenterol Hepatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of microwave ablation for periductal hepatocellular carcinoma with intraductal cooling of the central bile ducts through a percutaneous transhepatic cholangial drainage tube.
Naijian Ge, Jian Huang, Zhiyong Shi, Xiaohe Yu, Shuqun Shen, Yefa Yang

J Interv Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).
Jian Zhou, Hui-Chuan Sun, Zheng Wang, Wen-Ming Cong, Jian-Hua Wang, Jia-Mei Yang, Jian-Yong Yang, Ye-Fa Yang

Liver Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I reinforces antitumor activity of metuximab by reversing epithelial-mesenchymal transition via VEGFR-2 signaling in hepatocellular carcinoma.
Lu Wu, Bin Sun, Xuejing Lin, Chunying Liu, Haihua Qian, Yefa Yang

Genes Cells· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Role of Radiopharmaceuticals in Hepatocellular Carcinoma Treatment.
Lu Wu, Feng Shen, Yong Xia, Ye-Fa Yang

Anticancer Agents Med Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
Bin Huang, Lu Wu, Xin-Yuan Lu, Feng Xu, Cai-Feng Liu, Ning-Yang Jia, Ye-Fa Yang

Radiology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.
Shuqun Cheng, Jiamei Yang, Feng Shen, Weiping Zhou, Yi Wang, Guang Shun Yang, Yefa Yang, Hongyang Wang

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High leukocyte mtDNA content contributes to poor prognosis through ROS-mediated immunosuppression in hepatocellular carcinoma patients.
Xianli He, Falin Qu, Feng Zhou, Xingchun Zhou, Yibing Chen, Yefa Yang

Oncotarget· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis